SQSTM1 and metabolic dysfunction-associated steatohepatitis: The accumulated p62/SQSTM1-positive aggregate in the liver tissues contributed to disease progression in NASH and HCC and was correlated with the recurrence of HCC after curative ablation (Table 4) [513].